Viewpoint: Biotechnology gave us a COVID vaccine. Could that end the anti-GMO movement?

Print Friendly, PDF & Email
Credit: Nurphoto
Credit: Nurphoto
[T]he anti-GMO movement had been growing ever stronger over the years. But, if the reliably anti-GMO organization U.S. Right to Know is indicative of anything, anti-biotech activists have little to ramble about these days. Instead of obsessing over the alleged evils of Monsanto/Bayer, USRTK has spent much more time focusing on the coronavirus.

The scientific consensus is that SARS-CoV-2, the virus that causes COVID-19, jumped from animals to humans. Yet, USRTK is pushing the debunked conspiracy theory that the virus was made in China because it serves their “GMOs are bad” narrative. And they’re suing the National Institutes of Health (NIH) because… well, why not?

Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

Like all conspiracy theorists, anti-GMOrons just won’t go away. But now it appears that they have been marginalized thanks to companies like Pfizer and Moderna, which are using biotechnology to help rescue us from the COVID pandemic. Both companies are using RNA (which has been genetically edited or modified in some way) as the key ingredient in their coronavirus vaccines.

Related article:  Viewpoint: No, the placebo effect is not increasing, but bedside manners do impact perceived drug efficacy

The recent news that their vaccines are 90% and 95% effective, respectively, means that biotechnology is a savior of humanity rather than a horseman of the Apocalypse. This is obviously bad news for people who make a living by telling people that science is scary.

Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Trending green and going great — Every state in the US seeing decreased cases of COVID

Infographic: Trending green and going great — Every state in the US seeing decreased cases of COVID

The U.S. averaged fewer than 40,000 new cases per day over the past week. That’s a 21% improvement over the ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists